Clinical Trials
2 trialsNCT03251924 2023-02-28
A Dose Escalation and Combination Immunotherapy Study to Evaluate BMS-986226 Alone or in Combination With Nivolumab or Ipilimumab in Patients With Advanced Solid Tumors
Bristol-Myers Squibb
Phase 1/2 Terminated
NCT00000105 2017-11-29
Vaccination With Tetanus and KLH to Assess Immune Responses.
Masonic Cancer Center, University of Minnesota
Terminated